| BioVision |
2808-250 |
MTS Reagent
|
250 mg |
|
|
| BioVision |
2805-10 |
EZSolution™ Blasticidin S Hydrochloride, Sterile-Filtered
|
10 ml |
|
|
| BioVision |
2803-25 |
Cedrulatinib
|
25 mg |
|
|
| BioVision |
2804-5 |
DMXAA
|
5 mg |
|
|
| BioVision |
2804-25 |
DMXAA
|
25 mg |
|
|
| BioVision |
2803-5 |
Cedrulatinib
|
5 mg |
|
|
| BioVision |
2802-25 |
Tunicamycin
|
25 mg |
|
|
| BioVision |
2801-5 |
Smo agonist, SAG dihydrochloride
|
5 mg |
|
|
| BioVision |
2802-5 |
Tunicamycin
|
5 mg |
|
|
| BioVision |
2800-25 |
GSK-2118436 mesylate
|
25 mg |
|
|
| BioVision |
2801-1 |
Smo agonist, SAG dihydrochloride
|
1 mg |
|
|
| BioVision |
2799-25 |
WS3
|
25 mg |
|
|
| BioVision |
2800-5 |
GSK-2118436 mesylate
|
5 mg |
|
|
| BioVision |
2798-25 |
Trelagliptin succinate
|
25 mg |
|
|
| BioVision |
2798-5 |
Trelagliptin succinate
|
5 mg |
|
|
| BioVision |
2799-5 |
WS3
|
5 mg |
|
|
| BioVision |
2797-10 |
EZSolution™ 5-Fluoroorotic acid monohydrate (5-FOA)
|
10 ml |
|
|
| BioVision |
2795-25 |
GZD824
|
25 mg |
|
|
| BioVision |
2796-1G |
5-Fluoroorotic acid monohydrate (5-FOA)
|
1g |
|
|
| BioVision |
2796-5G |
5-Fluoroorotic acid monohydrate (5-FOA)
|
5 g |
|
|
| BioVision |
2794-25 |
CO-1686 (Rociletinib)
|
25 mg |
|
|
| BioVision |
2795-5 |
GZD824
|
5 mg |
|
|
| BioVision |
2793-25 |
GSK2636771
|
25 mg |
|
|
| BioVision |
2794-5 |
CO-1686 (Rociletinib)
|
5 mg |
|
|
| BioVision |
2793-5 |
GSK2636771
|
5 mg |
|
|
| BioVision |
2792-25 |
Elacridar
|
25 mg |
|
|
| BioVision |
2792-5 |
Elacridar
|
5 mg |
|
|
| BioVision |
2791-250 |
Biotin-PEG₄-amine
|
250 mg |
|
|
| BioVision |
2791-50 |
Biotin-PEG₄-amine
|
50 mg |
|
|
| BioVision |
2790-5 |
Nanaomycin A
|
5 mg |
|
|
| BioVision |
2790-25 |
Nanaomycin A
|
25 mg |
|
|
| BioVision |
2789-25 |
TW-37
|
25 mg |
|
|
| BioVision |
2789-5 |
TW-37
|
5 mg |
|
|
| BioVision |
2788-5 |
Ivachtin
|
5 mg |
|
|
| BioVision |
2787-5 |
Pan-caspase inhibitor, Q-VD(OMe)-OPh
|
5 mg |
|
|
| BioVision |
2788-1 |
Ivachtin
|
1 mg |
|
|
| BioVision |
2786-1 |
AZ10417808
|
1 mg |
|
|
| BioVision |
2786-5 |
AZ10417808
|
5 mg |
|
|
| BioVision |
2785-5 |
Gambogic acid
|
5 mg |
|
|
| BioVision |
2787-1 |
Pan-caspase inhibitor, Q-VD(OMe)-OPh
|
1 mg |
|
|
| BioVision |
2785-25 |
Gambogic acid
|
25 mg |
|
|
| BioVision |
2784-25 |
Apoptosis activator 2
|
25 mg |
|
|
| BioVision |
2782-5 |
Caspase-3 inhibitor, Z-DQMD-FMK
|
5 mg |
|
|
| BioVision |
2783-5 |
Apoptosis inhibitor
|
5 mg |
|
|
| BioVision |
2783-25 |
Apoptosis inhibitor
|
25 mg |
|
|
| BioVision |
2784-5 |
Apoptosis activator 2
|
5 mg |
|
|
| BioVision |
2781-25 |
VX-765
|
25 mg |
|
|
| BioVision |
2782-1 |
Caspase-3 inhibitor, Z-DQMD-FMK
|
1 mg |
|
|
| BioVision |
2781-5 |
VX-765
|
5 mg |
|
|
| BioVision |
2780-5 |
Caspase-3/7 Inhibitor
|
5 mg |
|
|